Diampa LXR (Empagliflozin+linagliptin+Metformin HCL) 5mg+2.5mg+1000mg

Diampa LXR (Empagliflozin + Linagliptin + Metformin HCL) 5mg + 2.5mg + 1000mg | Advanced Diabetes Management

Product Overview

Diampa LXR is a combination medication designed to effectively manage type 2 diabetes mellitus by improving blood sugar control. It contains three powerful active ingredients: Empagliflozin, Linagliptin, and Metformin HCL, each working together to regulate glucose levels, enhance insulin function, and reduce the risk of diabetes-related complications.

Key Benefits

Diampa LXR helps lower blood sugar levels by reducing glucose absorption in the kidneys, increasing insulin sensitivity, and regulating pancreatic function. It promotes better glycemic control, supports weight management, and may help reduce the risk of cardiovascular complications in diabetic patients.

How to Use Diampa LXR

This medication should be taken as prescribed by a healthcare professional, usually once or twice daily with meals to minimize stomach discomfort. The tablet should be swallowed whole with water and should not be crushed or chewed. Regular monitoring of blood sugar levels is recommended for optimal diabetes management.

Who Should Use It?

Diampa LXR is intended for adults with type 2 diabetes mellitus who require better blood sugar control when diet, exercise, and other medications are not sufficient. It is not suitable for individuals with type 1 diabetes or those with severe kidney or liver disease.

Important Information

Possible side effects include nausea, diarrhea, urinary tract infections, and mild dizziness. Patients should stay well-hydrated and be aware of any signs of low blood sugar (hypoglycemia) or ketoacidosis. Regular kidney function tests are advised while using this medication.

Diampa LXR is an effective solution for type 2 diabetes management, helping patients achieve stable blood sugar levels while reducing long-term health risks. Always use under medical supervision.